Insider Transactions in Q1 2021 at Organogenesis Holdings Inc. (ORGO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,050
-16.75%
|
$128,800
$16.5 P/Share
|
|
Feb 25
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
29,335
-19.64%
|
$440,025
$15.61 P/Share
|
|
Feb 24
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,154
-16.38%
|
$212,156
$14.7 P/Share
|
|
Feb 18
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
16,663
-10.65%
|
$199,956
$12.85 P/Share
|
|
Feb 17
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
89,375
-19.24%
|
$1,161,875
$13.56 P/Share
|
|
Feb 16
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
170,000
-64.75%
|
$2,040,000
$12.95 P/Share
|
|
Feb 16
2021
|
Arthur S Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+13.06%
|
-
|
|
Feb 16
2021
|
Joshua Alexander Tamaroff Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+17.77%
|
-
|
|
Feb 16
2021
|
Wayne D Mackie Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+2.75%
|
-
|
|
Feb 16
2021
|
Gary S. Gillheeney President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
51,626
+17.36%
|
-
|
|
Feb 16
2021
|
Patrick Bilbo Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,782
+6.08%
|
-
|
|
Feb 16
2021
|
Lori Freedman Chief Admin. and Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,808
+19.78%
|
-
|
|
Feb 16
2021
|
Brian Grow Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,782
+18.81%
|
-
|
|
Feb 16
2021
|
Antonio S. Montecalvo Vice President, Health Policy |
BUY
Grant, award, or other acquisition
|
Direct |
8,260
+10.38%
|
-
|
|
Feb 16
2021
|
David Francisco Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,965
+40.13%
|
-
|
|
Feb 16
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
111,406
-36.45%
|
$1,448,278
$13.12 P/Share
|
|
Feb 15
2021
|
David Francisco Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,396
+50.0%
|
-
|
|
Feb 12
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
99,918
-9.6%
|
$1,298,934
$13.53 P/Share
|
|
Feb 12
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
111,329
-14.27%
|
$1,447,277
$13.37 P/Share
|
|
Feb 11
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
23,840
-6.17%
|
$333,760
$14.02 P/Share
|
|
Feb 11
2021
|
Alan A. Ades Director |
SELL
Open market or private sale
|
Direct |
200,000
-0.29%
|
$600,000
$3.25 P/Share
|
|
Feb 11
2021
|
Glenn H Nussdorf Director |
SELL
Open market or private sale
|
Direct |
200,000
-0.29%
|
$600,000
$3.25 P/Share
|
|
Feb 11
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
69,127
-14.22%
|
$898,651
$13.82 P/Share
|
|
Jan 13
2021
|
Henry Hagopian Iii Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,700
+46.99%
|
-
|